Paper Review Records
全部论文审稿周期
30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
409
天
Untargeted Metabolomics of Dried Blood Spots for Inherited Metabolic Disorder Classification
作者
Jan‐Clemens Cremer; Lorenz Waltl; Viktorija Juric; Jakob Koch; Sabine Scholl‐Bürgi; Daniela Karall; Johannes Zschocke; Markus A. Keller展开收起
作者单位
1. Institute of Human Genetics, Medical University of Innsbruck Innsbruck Austria; 2. Department of Paediatrics I (Inherited Metabolic Disorders) Medical University of Innsbruck Innsbruck Austria展开收起
84
天
Bringing Untargeted Metabolomics to the Clinic: Real‐World Data and Implementation for Screening of Inherited Metabolic Diseases
作者
D. Augustijn; R. Bonte; M. C. Hagemeijer; J. Bierau; E. H. Jacobs; C. J. Klein‐de Ronde; E. van der Star; D. Y. van Haaften‐Visser; N. C. Peltenburg‐de Jong; C. Debuy; M. van Dijk; D. Vos; G. J. G. Ruijter; S. M. I. Goorden展开收起
作者单位
1. Centre of Lysosomal and Metabolic Diseases, Department of Clinical Genetics Erasmus Medical Centre Rotterdam the Netherlands; 2. Department of Clinical Chemistry Erasmus MC Rotterdam the Netherlands; 3. Centre of Lysosomal and Metabolic Diseases, Department of Paediatrics Erasmus Medical Centre Rotterdam the Netherlands; 4. Centre of Lysosomal and Metabolic Diseases, Department of Internal Medicine Erasmus Medical Centre Rotterdam the Netherlands; 5. Laboratory Genetic Metabolic Diseases, Department of Laboratory Medicine Amsterdam University Medical Centre Amsterdam the Netherlands展开收起
209
天
Migalastat Versus Enzyme Replacement Therapy in Treatment‐Naïve F abry Disease: Real‐World Evidence From the followME F abry Pathfinders Registry
作者
Peter Nordbeck; Agnieszka Kopiec; Noemi Hummel; Vera Gielen; Biliana O. Veleva‐Rotse; Alasdair MacCulloch展开收起
作者单位
1. University Hospital Würzburg Würzburg Germany; 2. Certara Krakow Poland; 3. Certara GmbH Lörrach Germany; 4. BioMarin UK Ltd London UK; 5. BioMarin Pharmaceutical Inc. Novato California USA展开收起
145
天
Nucleic Acid Therapeutics in Rare Disease: From Precision Medicine to Programmable Platforms
作者
Tomasz Z. Tomkiewicz; Siyamini Sivananthan; Paul Gissen; Haiyan Zhou展开收起
作者单位
1. Genetics and Genomic Medicine Research and Teaching Department Great Ormond Street Institute of Child Health, University College London London UK; 2. NIHR Great Ormond Street Hospital Biomedical Research Centre London UK展开收起
195
天
Thymidine Kinase 2 Deficiency in the Era of Approved Therapy: From Diagnosis to Evidence Across the Disease Spectrum
作者
Paloma Martin‐Jimenez; Cristina Domínguez‐González展开收起
作者单位
1. Neuromuscular Diseases Unit, Neurology Department Hospital Universitario 12 de Octubre Madrid Spain; 2. Medical‐Surgical Sciences Research, Faculty of Medicine Complutense University Madrid Spain; 3. Mitochondrial and Neuromuscular Research Group ’12 de Octubre’ imas12 Research Institute Madrid Spain; 4. Biomedical Network Research Centre on Rare Diseases (CIBERER), Instituto de Salud Carlos III Madrid Spain展开收起
83
天
Revisiting Inherited Metabolic Diseases ( IMDs ) Through the Lens of Selective Autophagy
作者
Marianna Maddaluno; Laura Cinque; Viviana Cetrangolo; Chiara De Leonibus展开收起
作者单位
1. Telethon Institute of Genetics and Medicine (TIGEM) Pozzuoli Italy; 2. Department of Clinical Medicine and Surgery Federico II University Naples Italy; 3. Department of Precision Medicine University of Campania “Luigi Vanvitelli” Naples Italy; 4. Department of Health Sciences University of Basilicata Potenza Italy展开收起
FAQ
JOURNAL OF INHERITED METABOLIC DISEASE审稿要多久?
截至2026-11-17,CrushSCI 收录了 JOURNAL OF INHERITED METABOLIC DISEASE 的 30 篇完整审稿记录。最快一篇从收稿到录用用了 35 天(Consensus Guidelines for Diagnosis and Management of Pyruvate Dehydrogenase Complex Deficiency,2026-05-29 收稿,2026-07-03 录用),最慢一篇用了 409 天;平均 157.6 天,中位数 145 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
